I have never understood why Sascha doesn’t mention Leronlimab by name more often.
Why is he on the SAB if he can’t even do us that one small favor? Our drug is making his career. It’s literally the least he could do.
(22)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
